Search

Your search keyword '"Barquilla-García A"' showing total 153 results

Search Constraints

Start Over You searched for: Author "Barquilla-García A" Remove constraint Author: "Barquilla-García A"
153 results on '"Barquilla-García A"'

Search Results

1. Analysis of case fatality rate of SARS-CoV-2 infection in the Spanish Autonomous Communities between March and May 2020.

3. Characteristics of the phenotypes in prevalent and incident cases of heart failure in primary care: IBERICAN study

5. Comparison of baseline clinical characteristics among people with type 2 diabetes on second-line therapy previously added with dapagliflozin or another oral glucose-lowering drug: AGORA study

6. Clinical characteristics, treatment, and blood pressure control in patients with hypertension seen by primary care physicians in Spain: the IBERICAN study

10. Elevated pulse pressure and cardiovascular risk associated in Spanish population attended in primary care: IBERICAN study

11. Evaluation of prophylaxis in primary prevention with acetylsalicylic acid in people with diabetes: A scoping review

13. Comprehensive management of risk factors in peripheral vascular disease. Expert consensus

18. Prevalence of hypotension in hypertensive treated patients within the Primary Care setting. The PRESCAP 2010 study

22. Posicionamiento para el manejo de la hipertensión arterial en atención primaria a partir del análisis crítico de las guías americana (2017) y europea (2018). Sociedad Española de Médicos de Atención Primaria (SEMERGEN)

23. Características basales y manejo clínico de los primeros 3.000 pacientes incluidos en el estudio IBERICAN (Identificación de la población española de riesgo cardiovascular y renal)

25. Clinical characteristics, treatment, and blood pressure control in patients with hypertension seen by primary care physicians in Spain: the IBERICAN study.

27. Evaluation of prophylaxis in primary prevention with acetylsalicylic acid in people with diabetes: A scoping review

29. TARGET ORGAN DAMAGE IN HYPERTENSIVE PATIENTS OF THE IBERICAN STUDY

30. ARTERIAL HYPERTENSION, CLINICAL CHARACTERISTICS OF PATIENTS INCLUDED IN THE IBERICAN STUDY

32. Comprehensive management of risk factors in peripheral vascular disease. Expert consensus

33. Prevalence of Hyperuricemia and Its Association with Cardiovascular Risk Factors and Subclinical Target Organ Damage

36. Prevalencia de la enfermedad renal crónica y factores asociados en la población asistida en atención primaria de España: resultados del estudio IBERICAN

37. Factores asociados al riesgo cardiovascular y enfermedad cardiovascular y renal en el estudio IBERICAN (Identificación de la poBlación Española de RIesgo CArdiovascular y reNal): resultados definitivos

38. Descripción de la muestra, diseño y métodos del estudio para la identificación de la población española de riesgo cardiovascular y renal (IBERICAN)

39. Prevalence of Hyperuricemia and Its Association with Cardiovascular Risk Factors and Subclinical Target Organ Damage

41. Tasas de letalidad por SARS-CoV-2 durante la segunda onda epidémica en España según Comunidades Autónomas

42. Prevalence of Chronic Heart Failure, Associated Factors, and Therapeutic Management in Primary Care Patients in Spain, IBERICAN Study

43. Prevalence of Hyperuricemia and Its Association with Cardiovascular Risk Factors and Subclinical Target Organ Damage.

44. Prevalence of Chronic Kidney Disease in Patients with Diabetes in Extremadura (Spain) during the Years 2012, 2013 and 2014: An Observational Study

45. Prevalence of diabetes and frequency of glycated haemoglobin monitoring in Extremadura (Spain) during 2012, 2013 and 2014: An observational study

46. Prevalencia de obesidad y comorbilidad cardiovascular asociada en los pacientes incluidos en el estudio IBERICAN (Identificación de la poBlación Española de RIesgo CArdiovascular y reNal)

47. Posicionamiento para el manejo de la hipertensión arterial en atención primaria a partir del análisis crítico de las guías americana (2017) y europea (2018). Sociedad Española de Médicos de Atención Primaria (SEMERGEN)

48. [Application of the PCR number of cycle threshold value (Ct) in COVID-19]

49. Comprehensive management of risk factors in peripheral vascular disease. Expert consensus

Catalog

Books, media, physical & digital resources